OsteoConnections

Thanks for visiting the official website and blog of the University Health Network and Mount Sinai Hospital Osteoporosis Program.

Osteoporosis is a major public health concern, with over 2 million Canadians currently suffering from the disease. This figure is expected to rise to 6.9 million by the end of the year.

Our clinic, led by Dr. Angela M. Cheung, provides diagnostic and clinical services to osteoporosis patients and people with low bone mass (referral). Every year, over 3000 patients walk through our clinic doors! We also have a dynamic research programme that is led by expert physicians and researchers in the field.

Please feel free to browse our website to learn more about osteoporosis, the research we conduct, and important tips for better bone health!

Participants Needed for osteogenesis imperfecta study

Recent Posts

Race/ethnic diferences in the prevalence of osteoporosis, falls and fractures: a cross‑sectional analysis of the Canadian Longitudinal Study on Aging

© International Osteoporosis Foundation and Bone Health and Osteoporosis Foundation 2022 Most of the published epidemiology on osteoporosis is derived from White populations; still many countries have increasing ethno-culturally diverse populations, leading to gaps in the development of population-specifc efective fracture prevention strategies. We describe diferences in prevalent fracture and bone mineral density patterns in … Continue reading Race/ethnic diferences in the prevalence of osteoporosis, falls and fractures: a cross‑sectional analysis of the Canadian Longitudinal Study on Aging

Bones Age by As Much As 10 Years After Long Periods in Space

From Medscape by Carolyn Crist Prolonged spaceflight can damage bone structure permanently and age parts of the skeleton prematurely by as much as 10 years, according to a new report. Adapted training programs and certain medications could better protect astronauts involved with future space missions, particularly ones that seek to travel longer distances and for … Continue reading Bones Age by As Much As 10 Years After Long Periods in Space

Comparative Fracture Risk During Osteoporosis Drug Holidays After Long-Term Risedronate Versus Alendronate Therapy

A Propensity Score–Matched Cohort Study Abstract Background: An osteoporosis drug holiday is recommended for most patients after 3 to 5 years of therapy. Risedronate has a shorter half-life than alendronate, and thus the residual length of fracture protection may be shorter. Objective: To examine the comparative risks of drug holidays after long-term (≥3 years) risedronate … Continue reading Comparative Fracture Risk During Osteoporosis Drug Holidays After Long-Term Risedronate Versus Alendronate Therapy

More Posts